Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Regulatory News (CYAN)

Share Price Information for Cyanconnode (CYAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.30
Bid: 8.20
Ask: 8.40
Change: 0.00 (0.00%)
Spread: 0.20 (2.439%)
Open: 8.30
High: 8.30
Low: 8.30
Prev. Close: 8.30
CYAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Shareholding and Issue of Options

28 Nov 2014 10:27

RNS Number : 3078Y
Cyan Holdings Plc
28 November 2014
 



Cyan Holdings plc

("Cyan" or the "Company")

 

Director Shareholding and Issue of Options

 

Cyan Holdings plc (AIM:CYAN.L), the integrated system and software design company delivering mesh based flexible wireless solutions for utility metering and lighting control, was notified yesterday that Harry Berry, Non-Executive Director, purchased 7,000,000 ordinary shares of 0.01p in the Company ("Ordinary Shares") yesterday, at a price of 0.29375 pence per share.

This brings Harry Berry's interest in the Company's current issued share capital to 17,714,286 Ordinary Shares, being approximately 0.40% of the current issued share capital.

Furthermore, pursuant to the Cyan Non-Executive Share Plan, which is detailed below, and following the above purchase yesterday, the Company will now grant options over 7,000,000 Ordinary Shares with an exercise price of 0.29375 pence per Ordinary Share to Harry Berry. Following this grant, Harry Berry will hold options over 12,000,000 Ordinary Shares.

Cyan Non-Executive Share Plan

The Board has adopted a share subscription and option plan in order to retain and attract Non-Executive Directors.

Existing and future Non-Executive Directors will be offered the opportunity to purchase up to a maximum of £200,000 for ordinary shares in the Company at the then current market value and receive an associated grant of options over an equal number of ordinary shares at the same market value.

The key terms of the subscription and options are as follows:

· The Non-Executive would decide the number of ordinary shares that he or she wishes to purchase (up to the maximum subscription of £200,000) at the then market price.

· The Company will grant the Non-Executive options to subscribe for an equal number of ordinary shares exercisable at the same market price per share.

· The options will ordinarily be exercisable only after the fourth anniversary of the date of grant.

· The options must be exercised in any event prior to the tenth anniversary of the date of grant.

· The options may be exercised in full prior to the fourth anniversary of the date of grant in the event of a successful takeover of the Company.

 

Enquiries:

Cyan Holdings plc

www.cyantechnology.com

John Cronin, Executive Chairman

 

Tel: +44 (0) 1954 234 400

Allenby Capital Limited

Nominated Adviser and Joint Broker

Jeremy Porter / Chris Crawford

 

Hume Capital Securities plc

Joint Broker

Jon Belliss

 

Tel: +44 (0) 20 3328 5656

 

 

 

Tel: +44 (0) 20 7101 7070

Walbrook PR

Financial PR

 

cyan@walbrookpr.com

Paul Cornelius

Tel: +44(0) 20 7933 8780

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAEFPAALLFFF
Date   Source Headline
18th Apr 20247:00 amRNSAppointment of Joint Broker
17th Apr 20241:56 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
15th Apr 20247:00 amRNSOrder For A New Deployment In India
12th Apr 20247:00 amRNSMiddle East Energy Leadership Summit 2024
15th Jan 20247:00 amRNSAppointment of Non-Executive Director
11th Jan 20247:00 amRNSOrder For One Million Omnimesh Modules
27th Dec 20234:18 pmRNSDirector Dealing
19th Dec 20237:00 amRNSInterim Results
6th Dec 20231:32 pmRNSChange of Registered Office
1st Dec 20234:18 pmRNSHolding(s) in Company
21st Nov 20232:31 pmRNSHolding(s) in Company
20th Nov 20236:14 pmRNSIssue of Share Options – Correction
20th Nov 20237:00 amRNSNamed as One of the Fastest Growing Companies
17th Nov 20233:45 pmRNSDirector Option Grants
17th Nov 20238:30 amRNSHolding(s) in Company
16th Nov 202312:48 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSRanked 2nd Fastest-Growing UK Company in India
13th Nov 20236:11 pmRNSPlacing and Subscription – update
9th Nov 20238:02 amRNSResult of Oversubscribed Placing and Subscription
8th Nov 20235:24 pmRNSProposed Placing and Subscription to Raise c.£2.5m
31st Oct 20237:15 amRNSContract in the Middle East and North Africa
10th Oct 20237:00 amRNSOrder for 300,000 Omnimesh Modules
5th Oct 20237:00 amRNSTrading Update
24th Aug 202312:18 pmRNSResult of AGM
17th Aug 20231:00 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNS2023 Annual General Meeting
4th Aug 20235:34 pmRNSDirector Dealing
2nd Aug 20237:00 amRNSOrder for 300,000 Omnimesh Modules
26th Jul 20235:34 pmRNSCorrection: Final Results
26th Jul 20237:00 amRNSFinal Results
25th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jul 20237:00 amRNSTrading Update
22nd Jun 20237:00 amRNSCyanConnode India is a Start-Up 50 Trailblazer
25th May 20238:10 amRNSOrder for 600,000 Omnimesh Modules
9th May 20233:45 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSInterview with MD & CEO for CyanConnode India
3rd Apr 20237:00 amRNSCyanConnode and Alfanar Sign MOU for AMI projects
21st Mar 20237:15 amRNSHardman Research - Acceleration and revenue uplift
13th Mar 20237:00 amRNSCyanConnode Banking Arrangements
7th Mar 20237:00 amRNSCollaboration with Silicon Laboratories
6th Mar 20237:00 amRNSAppointment of Nominated and Financial Adviser
6th Feb 20238:51 amRNSStrategic Framework Agreement - Replacement
6th Feb 20238:21 amRNSStrategic Framework Agreement
6th Feb 20237:00 amRNSStrategic Framework Agreement
31st Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20238:00 amRNSResult of Oversubscribed Placing and Subscription
23rd Jan 20235:11 pmRNSProposed Placing and Subscription
19th Jan 20237:00 amRNSChange of Adviser
4th Jan 20237:00 amRNSOrder From New Partner

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.